FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
03/21/2024
cardiovascular disease
cardiovascular disease
06/06/2017
The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.
06/06/2017